Central origin of fatigability in Myalgic encephalomyelitis/chronic fatigue syndrome revealed by multimodal neuroimaging. [PDF]
Bedard P +8 more
europepmc +1 more source
A cardiometabolic perspective on post-exertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID. [PDF]
Westermeier F +5 more
europepmc +1 more source
Underuse of Pharmacologic Therapies for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Before Specialist Evaluation. [PDF]
Grach SL +7 more
europepmc +1 more source
REenergizeME: intermittent hypoxia-hyperoxia treatment for myalgic encephalomyelitis/chronic fatigue syndrome-protocol for a randomised, placebo-controlled trial. [PDF]
Nochi M +14 more
europepmc +1 more source
Association between myalgic encephalomyelitis/chronic fatigue syndrome and irritable bowel syndrome: a systematic review and meta-analysis. [PDF]
Rajabi N, Ramdass PVAK.
europepmc +1 more source
Total blood volume and red blood cell volume are not associated with orthostatic intolerance in adults with myalgic encephalomyelitis/chronic fatigue syndrome. [PDF]
Yamazaki T +6 more
europepmc +1 more source
Handgrip strength in children, adolescents, and young adults with suspected myalgic encephalomyelitis/chronic fatigue syndrome. [PDF]
Mihatsch L +18 more
europepmc +1 more source
Authors' Response to "Comment on 'SMPDL3B as a novel biomarker and therapeutic target in myalgic encephalomyelitis'". [PDF]
Rostami-Afshari B +3 more
europepmc +1 more source

